Total Neoadjuvant Therapy With mFOLFOX and Short-course Radiation in Resectable Rectal Cancer
Clinical trial NCT04643366 · RECRUITING
Trial details
- NCT number
- NCT04643366
- Sponsor
- Virginia Commonwealth University
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-28
- Primary completion
- 2030-01-31
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.